Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia

Active, not recruitingOBSERVATIONAL
Enrollment

369

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Staphylococcus Aureus Bacteremia
Trial Locations (6)

3000

The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne

Unknown

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

08916

Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona

08036

Hospital Clinic de Barcelona, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
collaborator

Institut d'Investigació Biomèdica de Bellvitge

OTHER

lead

Hospital Universitari de Bellvitge

OTHER

NCT06695832 - Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia | Biotech Hunter | Biotech Hunter